Understanding treatment use after leaving opioid addiction programs
Official title: Treatment Utilization During Community Reentry of Opioid Use Disorder Inpatients
Funded at University of Rhode Island · NIH-10997506 · Data updated 2026-11-12
This study looks at how people with opioid use disorder get help after leaving treatment programs and aims to find ways to better support them during the risky time right after they return home.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rhode Island NIH-funded |
| Lab location | 1 site (Kingston, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $48,974 |
| NIH project number | 1F31DA060010-01A1 |
| Project ID | NIH-10997506 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older who are transitioning from residential treatment for opioid use disorder back to their communities.
✕Less likely to help
Patients who are not currently undergoing treatment for opioid use disorder or who are not in the re-entry phase may not benefit from this research.
What this research studies
This research investigates how individuals with opioid use disorder (OUD) utilize treatment services after returning to their communities from residential programs. It focuses on the critical period following discharge, where the risk of relapse and overdose is highest. By using advanced methods like ecological momentary assessment and machine learning, the study aims to identify factors that influence treatment engagement during this vulnerable time. The goal is to improve continuity of care and support recovery outcomes for individuals transitioning back to their communities.
Why it matters
Potential benefit: If successful, this research could lead to better support systems for individuals recovering from opioid use disorder, reducing the risk of relapse and overdose.
How similar studies have gone: Other research has shown success in using similar approaches to improve treatment engagement and outcomes for individuals with substance use disorders.
Where this research is happening
-
University of Rhode Island
Kingston, United States Active
Researchers
- Principal investigator: Newberger, Noam — University of Rhode Island
- Study coordinator: Newberger, Noam
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.